Zobrazeno 1 - 10
of 1 291
pro vyhledávání: '"Kerchner A"'
Autor:
Melanie J. Plastini, Carla Abdelnour, Christina B. Young, Edward N. Wilson, Marian Shahid‐Besanti, Jennifer Lamoureux, Katrin I. Andreasson, Geoffrey A. Kerchner, Thomas J. Montine, Victor W. Henderson, Kathleen L. Poston
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 11, Iss 5, Pp 1197-1210 (2024)
Abstract Objective More than half of neurodegenerative disease patients have multiple pathologies at autopsy; however, most receive one diagnosis during life. We used the α‐synuclein seed amplification assay (αSyn‐SAA) and CSF biomarkers for am
Externí odkaz:
https://doaj.org/article/340d601fd43e42beb69b9417cf089816
Autor:
Moreira, José E., Barton, Kit, Battle, Steven, Bergner, Peter, Bertran, Ramon, Bhat, Puneeth, Caldeira, Pedro, Edelsohn, David, Fossum, Gordon, Frey, Brad, Ivanovic, Nemanja, Kerchner, Chip, Lim, Vincent, Kapoor, Shakti, Filho, Tulio Machado, Mueller, Silvia Melitta, Olsson, Brett, Sadasivam, Satish, Saleil, Baptiste, Schmidt, Bill, Srinivasaraghavan, Rajalakshmi, Srivatsan, Shricharan, Thompto, Brian, Wagner, Andreas, Wu, Nelson
Power ISA(TM) Version 3.1 has introduced a new family of matrix math instructions, collectively known as the Matrix-Multiply Assist (MMA) facility. The instructions in this facility implement numerical linear algebra operations on small matrices and
Externí odkaz:
http://arxiv.org/abs/2104.03142
Autor:
Kerchner, Jody L.1 (AUTHOR) jody.kerchner@oberlin.edu
Publikováno v:
International Journal of Community Music. Jun2024, Vol. 17 Issue 2, p233-248. 16p.
Autor:
Sandra M. Sanabria Bohórquez, Suzanne Baker, Paul T. Manser, Matteo Tonietto, Christopher Galli, Kristin R. Wildsmith, Yixuan Zou, Geoffrey A. Kerchner, Robby Weimer, Edmond Teng
Publikováno v:
Frontiers in Neuroimaging, Vol 3 (2024)
PurposeWe evaluated the impact of partial volume correction (PVC) methods on the quantification of longitudinal [18F]GTP1 tau positron-emission tomography (PET) in Alzheimer's disease and the suitability of describing the tau pathology burden tempora
Externí odkaz:
https://doaj.org/article/935c608a68ca4a409b94bd58178354e4
Autor:
David A Broniatowski, Daniel Kerchner, Fouzia Farooq, Xiaolei Huang, Amelia M Jamison, Mark Dredze, Sandra Crouse Quinn, John W Ayers
Publikováno v:
PLoS ONE, Vol 19, Iss 2, p e0298907 (2024)
[This corrects the article DOI: 10.1371/journal.pone.0261768.].
Externí odkaz:
https://doaj.org/article/8f01d7abbacd481ba262e6a0f58036da
Autor:
Broniatowski, David A., Kerchner, Daniel, Farooq, Fouzia, Huang, Xiaolei, Jamison, Amelia M., Dredze, Mark, Quinn, Sandra Crouse
On February 2, 2020, the World Health Organization declared a COVID-19 social media "infodemic", with special attention to misinformation -- frequently understood as false claims. To understand the infodemic's scope and scale, we analyzed over 500 mi
Externí odkaz:
http://arxiv.org/abs/2007.09682
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kathleen A. Welsh‐Bohmer, Geoffrey A. Kerchner, Shobha Dhadda, Miguel Garcia, David S. Miller, Fanni Natanegara, Lars Lau Raket, Weining Robieson, Eric R. Siemers, Maria C. Carrillo, Christopher J. Weber
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 9, Iss 4, Pp n/a-n/a (2023)
Abstract The efficient and accurate execution of clinical trials testing novel treatments for Alzheimer's disease (AD) is a critical component of the field's collective efforts to develop effective disease‐modifying treatments for AD. The lengthy a
Externí odkaz:
https://doaj.org/article/b8fe5eb288c64421be7d95e7fa3df0d5
Autor:
Edward N. Wilson, Christina B. Young, Javier Ramos Benitez, Michelle S. Swarovski, Igor Feinstein, Manu Vandijck, Yann Le Guen, Nandita M. Kasireddy, Marian Shahid, Nicole K. Corso, Qian Wang, Gabriel Kennedy, Alexandra N. Trelle, Betty Lind, Divya Channappa, Malia Belnap, Veronica Ramirez, Irina Skylar-Scott, Kyan Younes, Maya V. Yutsis, Nathalie Le Bastard, Joseph F. Quinn, Christopher H. van Dyck, Angus Nairn, Carolyn A. Fredericks, Lu Tian, Geoffrey A. Kerchner, Thomas J. Montine, Sharon J. Sha, Guido Davidzon, Victor W. Henderson, Frank M. Longo, Michael D. Greicius, Anthony D. Wagner, Tony Wyss-Coray, Kathleen L. Poston, Elizabeth C. Mormino, Katrin I. Andreasson
Publikováno v:
Alzheimer’s Research & Therapy, Vol 14, Iss 1, Pp 1-12 (2022)
Abstract Background The recent promise of disease-modifying therapies for Alzheimer’s disease (AD) has reinforced the need for accurate biomarkers for early disease detection, diagnosis and treatment monitoring. Advances in the development of novel
Externí odkaz:
https://doaj.org/article/a7c72b7b806e4d5f9c4b0862e6246e4f
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.